2025-04-16T08:11:14-05:00 2024-06-30 521392008 GELMAN ROSENBERG & FREEDMAN 4550 MONTGOMERY AVE SUITE 800N BETHESDA MD 208142930 990 2023-07-01 860684975 THE ARIZONA CLINICAL ONCOLOGY SOCIETY INC ARIZ 3019849496 CO ACCC 1801 RESEARCH BLVD 400 ROCKVILLE MD 20850 MANPREET K CHADHA TREASURER 3019849496 2025-04-16 1 0 FREDERICK U LONGWOOD P00439715 3019519090 2023 2025-03-06 01:10:19Z ALEJANDRO RECIO-BOILES C/O ACCC 1801 RESEARCH BLVD 400 ROCKVILLE MD 20850 433658 0 X WWW.TACOS-ONCOLOGY.COM X 2009 AZ SEE PART III, LINE 1. 12 12 0 12 0 0 240000 354000 92750 76780 1949 2878 0 0 334699 433658 500 4500 0 0 0 0 0 0 0 235329 261983 235829 266483 98870 167175 350698 589455 24736 96313 325962 493142 TO PROVIDE ADVOCACY FOR CANCER PATIENTS AND TO PROMOTE STANDARDS OF EXCELLENCE FOR HIGH-QUALITY CANCER CARE. 0 0 PROGRAM SERVICE ACCOMPLISHMENTS DURING THE YEAR:- HOSTED TWO SUCCESSFUL ANNUAL CONFERENCES WITH NATIONAL EXPERTS WHO DISCUSSED THE LATEST DEVELOPMENT IN ONCOLOGY TREATMENTS AND ECONOMIC TRENDS.- SERVED AS AN INFORMATIONAL RESOURCE FOR MULTIDISCIPLINARY CANCER CARE TEAMS IN ARIZONA THROUGH REGULAR DISSEMINATION OF ONCOLOGY NEWS AND HEALTHCARE POLICY UPDATES ONLINE.- COMPLETED AN EDUCATIONAL PROJECT FOR ADDRESSING CANCER CARE DISPARITIES IN THE COMMUNITY SETTING FOCUSING ON THE AMERICAN INDIANS IN AZ. 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 12 0 1 0 0 0 0 0 1 1 0 0 0 X 12 12 0 1 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 0 0 0 X MANPREET K CHADHA 3019849496 C/O ACCC 1801 RESEARCH BLVD 400 ROCKVILLE MD 20850 X ALEJANDRO RECIO-BOILES MD FACP PRESIDENT 1.00 X X 0 0 0 RAJU VADDEPALLY MD IMMEDIATE PAST PRESIDENT 1.00 X X 0 0 0 SHARAD KHURANA MD MSC PRESIDENT-ELECT 1.00 X X 0 0 0 CHAD C CHERINGTON MD SECRETARY/TREASURER 1.00 X X 0 0 0 RAJESH BAGAI MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 MANPREET K CHADHA MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 IAN DEROOCK MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 ABHINAV B CHANDRA MD DIRECTOR-AT-LARGE 1.00 X 0 0 0 MAHESH SEETHARAM MD FACP DIRECTOR-AT-LARGE 1.00 X 0 0 0 JODY PELUSI PHD FNP AOCNP DIRECTOR-AT-LARGE 1.00 X 0 0 0 MADAPPA N KUNDRANDA MD PHD FACP - DIRECTOR-AT-LARGE 1.00 X 0 0 0 RUTH WALKER-SIMELTON DIRECTOR-AT-LARGE (ADMINISTRATOR) 1.00 X 0 0 0 0 0 0 0 0 0 0 0 354000 354000 MEMBERSHIP MEETING 900099 39000 39000 WEBINAR INCOME 900099 29000 29000 MEMBERSHIP DUES 900099 8780 8780 76780 2878 2878 433658 76780 0 2878 4500 99200 155 2500 4528 2944 968 10251 136163 665 MISCELLANEOUS 2701 ACCC CHAPTER DUES 1732 MEMBERSHIP 176 266483 293480 512289 5163 22228 52055 54938 350698 589455 20686 94163 4050 2150 24736 96313 X 325962 493142 325962 493142 350698 589455 167175 5 0 X 0 0 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 1 0 FORM 990, PART VI, SECTION A, LINE 3 THE ORGANIZATION DELEGATED CONTROL OVER THE MANAGEMENT DUTIES TO ACCC. PRIOR TO SIGNING THE AGREEMENT, AN INDEPENDENT COMPARISON OF THE MANAGEMENT FEE WAS CONDUCTED AND APPROVAL OF THE MANAGEMENT FIRM'S FEE WAS OBTAINED FROM ALL BOARD MEMBERS. THE DECISION TO SIGN THE AGREEMENT WAS DOCUMENTED IN THE ORGANIZATION'S BOARD MEETING MINUTES. THE TOTAL AMOUNT PAID TO ACCC DURING FY24 WAS $99,200. FORM 990, PART VI, SECTION A, LINE 6 THE ORGANIZATION HAS SIX CLASSES OF MEMBERSHIP; REGULAR, GROUP, RETIRED, ASSOCIATE, AFFILIATE AND FELLOW. FORM 990, PART VI, SECTION A, LINE 7A THE ORGANIZATION HAS MEMBERS WHO MAY ELECT ONE OR MORE MEMBERS OF THE GOVERNING BODY. THE ELECTION OF OFFICERS OCCURS EVERY OTHER YEAR. FORM 990, PART VI, SECTION A, LINE 7B CHANGES TO BY-LAWS MUST BE APPROVED BY MEMBERSHIP. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 WAS PREPARED BY THE OUTSIDE ACCOUNTANTS AND REVIEWED BY THE PRESIDENT AND BOARD MEMBERS. A COPY OF THE 990 WAS PROVIDED TO THE ENTIRE BOARD PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C ELECTED BOARD MEMBERS SIGN A CONFLICT OF INTEREST FORM ANNUALLY. IF THE BOARD HAS REASONABLE CAUSE TO BELIEVE A MEMBER HAS FAILED TO DISCLOSE AN ACTUAL OR POSSIBLE CONFLICT OF INTEREST, THE BOARD GIVES THE MEMBER THE OPPORTUNITY TO EXPLAIN THE ALLEGED FAILURE TO DISCLOSE. IF, AFTER FURTHER INVESTIGATION, THE BOARD DETERMINES THAT A FAILURE TO DISCLOSE HAS OCCURRED, IT TAKES APPROPRIATE DISCIPLINARY AND CORRECTIVE ACTION. - AN INTERESTED PERSON MAY MAKE A PRESENTATION AT THE BOARD OF DIRECTORS OR COMMITTEE MEETING, BUT AFTER THE PRESENTATION, HE/SHE LEAVES THE MEETING DURING THE DISCUSSION OF, AND THE VOTE ON, THE TRANSACTION OR ARRANGEMENT INVOLVING THE POSSIBLE CONFLICT OF INTEREST. - THE PRESIDENT OR COMMITTEE CHAIR, IF APPROPRIATE, APPOINTS A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. - AFTER EXERCISING DUE DILIGENCE, THE BOARD OF DIRECTORS OR COMMITTEE DETERMINES WHETHER THE ORGANIZATION CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. - IF A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT IS NOT REASONABLY POSSIBLE UNDER CIRCUMSTANCES NOT PRODUCING A CONFLICT OF INTEREST, THE BOARD OF DIRECTORS OR COMMITTEE DETERMINES BY A MAJORITY VOTE OF THE DISINTERESTED DIRECTORS WHETHER THE TRANSACTION OR ARRANGEMENT IS IN THE ORGANIZATION'S BEST INTEREST, FOR ITS OWN BENEFIT, AND WHETHER IT IS FAIR AND REASONABLE. IN CONFORMITY WITH THE ABOVE DETERMINATION, IT MAKES ITS DECISION AS TO WHETHER TO ENTER INTO THE TRANSACTION OR ARRANGEMENT. FORM 990, PART VI, SECTION C, LINE 19 THE ARIZONA CLINICAL ONCOLOGY SOCIETY MAINTAINS ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AT ITS MANAGEMENT OFFICE IN ROCKVILLE, MARYLAND. THESE DOCUMENTS ARE MADE AVAILABLE TO THE GENERAL PUBLIC UPON REQUEST.